Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-05-02 | Mr. Alton is well-suited to serve on our Board. His extensive industry experience and broad global experience across multiple business areas and his deep insight in infectious disease will contribute to the Board’s understanding of our mission and corporate goals. |
| 2023-04-28 | J.D., Stanford University; Bachelor of Science in Legal Studies, University of California, Berkeley |
| 2024-04-29 | J.D., Stanford University; Bachelor of Science in Legal Studies, University of California, Berkeley |
Data sourced from SEC filings. Last updated: 2025-10-12